Cargando…
Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA-21 expression, Akt and the Bcl-2/Bax pathway
Trimetazidine is a piperazine-derived metabolic agent, which exerts cell protective effects and has been reported to be efficient in the treatment of chronic stable angina pectoris. In addition, it has been shown to exert protection against acute myocardial infarction. The present study aimed to inv...
Autores principales: | Ma, Ning, Bai, Jingyun, Zhang, Weihua, Luo, Hong, Zhang, Xin, Liu, Donghai, Qiao, Chenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101925/ https://www.ncbi.nlm.nih.gov/pubmed/27666568 http://dx.doi.org/10.3892/mmr.2016.5773 |
Ejemplares similares
-
Protective effect of gastrodin on myocardial ischemia-reperfusion injury and the expression of Bax and Bcl-2
por: Han, Xiao, et al.
Publicado: (2019) -
Trimetazidine for prevention of induced ischemia and reperfusion of guinea pig retina
por: Demir, T, et al.
Publicado: (2010) -
Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway
por: Tu, Yingfeng, et al.
Publicado: (2013) -
Genome-wide analysis revealed the dysregulation of RNA binding protein-correlated alternative splicing events in myocardial ischemia reperfusion injury
por: Ma, Ning, et al.
Publicado: (2023) -
Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)